IGKV2-26 and diabetes mellitus: While HLA class II molecules in NOD mice are not able to promote T1D, expression of the HLA A2.1 allele accelerates diabetes development, providing a model for identifying peptides targeted by A2.1-restricted CD8+ T cells and for testing antigen-specific immunotherapy (122, 123).